2004N-0559 - Joint Meeting of the Arthritis Advisory Committee and the Drug Safety and Risk Management Advisory Committee

  


  

  


  

  


  

  


  

  
FDA Comment Number : 
  

  
EC78
  



  

  

  



  

  
Submitter : 
  

  
Dr. James Wood
  

  
Date & Time: 
  

  
02/07/2005 07:02:30
  



  

  
Organization : 
  

  
Harbor Hospital of Baltimore
  



  

  
Health Professional
  


  

  
Category : 
  


  

  
Issue Areas/Comments 
  


  

  



  

  
GENERAL
  


  

  



  

  
GENERAL
  


  

  



  

  
 The COX2's have been a mainstay of my practise since released several yrs. ago.  Like any med, risk/benefit is a major consideration when prescribing. The marked decrease of GI side effects and events and the one pill dosing are very attractive. Clarification of the true risk with these meds would be very helpful. I seems like a lot of hype without much substance at this time.